Do not take anti-retroviral medications for at least one month prior to initiating stem cell mobilization. Anti-retroviral medications may interfere with the manufacturing of LENMELDY.
Source: NLP:atidarsagene autotemcel
Atidarsagene Autotemcel Interactions
Brand names: Lenmeldy
Route: Intravenous
Contraindications
4 CONTRAINDICATIONS None. None ( 4 )
Pregnancy & Breastfeeding
8.1 Pregnancy Risk Summary There are no clinical data from the use of LENMELDY in pregnant women. No animal reproductive and developmental toxicity studies have been conducted with LENMELDY to assess whether it can cause fetal harm when administered to a pregnant woman. LENMELDY must not be administered during pregnancy because of the risk associated with myeloablative conditioning. Pregnancy after LENMELDY infusion should be discussed with the treating physician. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively.
2 interactions on record
Vaccination is not recommended during the 6 weeks preceding myeloablative conditioning and until hematological recovery following LENMELDY treatment. Safety and effectiveness of vaccination during or following treatment have not been studied.
Source: NLP:atidarsagene autotemcel